• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $TLRY

    Tilray Brands Inc.

    Subscribe to $TLRY
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.

    IPO Year: 2018

    Exchange: NASDAQ

    Website: tilray.com

    Recent Analyst Ratings for Tilray Brands Inc.

    DatePrice TargetRatingAnalyst
    4/5/2024$2.25 → $2.75Neutral
    Alliance Global Partners
    11/2/2022$3.90Mkt Perform
    Bernstein
    7/29/2022$3.00Hold → Sell
    The Benchmark Company
    3/4/2022$9.00Hold → Buy
    Canaccord Genuity
    1/11/2022$7.40 → $6.90Neutral
    Cantor Fitzgerald
    1/7/2022$11.80 → $7.40Neutral
    Cantor Fitzgerald
    11/18/2021$10.00Underweight
    Barclays
    11/1/2021$18.00 → $11.80Overweight → Neutral
    Cantor Fitzgerald
    10/8/2021$14.00 → $12.00Neutral
    CIBC
    9/17/2021$19.00 → $18.00Overweight
    Cantor Fitzgerald
    See more ratings

    Tilray Brands Inc. SEC Filings

    See more
    • Tilray Brands Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Tilray Brands, Inc. (0001731348) (Filer)

      6/10/25 5:00:39 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form DEFA14A filed by Tilray Brands Inc.

      DEFA14A - Tilray Brands, Inc. (0001731348) (Filer)

      4/28/25 4:55:34 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form DEF 14A filed by Tilray Brands Inc.

      DEF 14A - Tilray Brands, Inc. (0001731348) (Filer)

      4/28/25 4:53:44 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities

      8-K - Tilray Brands, Inc. (0001731348) (Filer)

      4/25/25 4:06:00 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form PRE 14A filed by Tilray Brands Inc.

      PRE 14A - Tilray Brands, Inc. (0001731348) (Filer)

      4/17/25 8:32:23 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Tilray Brands, Inc. (0001731348) (Filer)

      4/17/25 7:42:47 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 10-Q filed by Tilray Brands Inc.

      10-Q - Tilray Brands, Inc. (0001731348) (Filer)

      4/8/25 5:01:26 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Tilray Brands, Inc. (0001731348) (Filer)

      4/8/25 7:00:13 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Tilray Brands, Inc. (0001731348) (Filer)

      3/25/25 4:35:08 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities

      8-K - Tilray Brands, Inc. (0001731348) (Filer)

      3/10/25 5:06:56 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care

    Tilray Brands Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President and CEO Simon Irwin D exercised 1,178,109 shares at a strike of $0.41 and covered exercise/tax liability with 647,960 shares, increasing direct ownership by 16% to 3,776,633 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      6/4/25 5:01:34 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Chief Financial Officer Merton Carl A exercised 174,477 shares at a strike of $0.41 and covered exercise/tax liability with 95,963 shares, increasing direct ownership by 11% to 764,569 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      6/4/25 5:01:02 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Chief Strategy Officer Faltischek Denise M exercised 249,353 shares at a strike of $0.41 and covered exercise/tax liability with 127,171 shares, increasing direct ownership by 23% to 657,875 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      6/4/25 5:00:48 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Global General Counsel Gendel Mitchell exercised 231,218 shares at a strike of $0.41 and covered exercise/tax liability with 117,922 shares, increasing direct ownership by 27% to 533,564 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      6/4/25 5:00:38 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 4 filed by Director Cohen Steven Michael

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      1/8/25 4:16:07 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • New insider Cohen Steven Michael claimed no ownership of stock in the company (SEC Form 3)

      3 - Tilray Brands, Inc. (0001731348) (Issuer)

      12/17/24 4:05:56 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Chief Financial Officer Merton Carl A bought $35,360 worth of shares (26,000 units at $1.36) (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      11/18/24 11:29:05 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • President and CEO Simon Irwin D exercised 706,214 shares at a strike of $2.03 and covered exercise/tax liability with 390,537 shares, increasing direct ownership by 11% to 3,246,484 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      8/2/24 4:08:46 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Chief Financial Officer Merton Carl A exercised 93,926 shares at a strike of $2.03 and covered exercise/tax liability with 43,357 shares, increasing direct ownership by 8% to 660,055 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      8/2/24 4:08:13 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Global General Counsel Gendel Mitchell exercised 93,926 shares at a strike of $2.03 and covered exercise/tax liability with 47,950 shares, increasing direct ownership by 12% to 420,268 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      8/2/24 4:07:41 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care

    Tilray Brands Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Alliance Global Partners reiterated coverage on Tilray with a new price target

      Alliance Global Partners reiterated coverage of Tilray with a rating of Neutral and set a new price target of $2.75 from $2.25 previously

      4/5/24 7:39:50 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Bernstein initiated coverage on Tilray with a new price target

      Bernstein initiated coverage of Tilray with a rating of Mkt Perform and set a new price target of $3.90

      11/2/22 6:37:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray downgraded by The Benchmark Company with a new price target

      The Benchmark Company downgraded Tilray from Hold to Sell and set a new price target of $3.00

      7/29/22 7:19:40 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray upgraded by Canaccord Genuity with a new price target

      Canaccord Genuity upgraded Tilray from Hold to Buy and set a new price target of $9.00

      3/4/22 6:10:38 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cantor Fitzgerald reiterated coverage on Tilray with a new price target

      Cantor Fitzgerald reiterated coverage of Tilray with a rating of Neutral and set a new price target of $6.90 from $7.40 previously

      1/11/22 4:39:43 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cantor Fitzgerald reiterated coverage on Tilray with a new price target

      Cantor Fitzgerald reiterated coverage of Tilray with a rating of Neutral and set a new price target of $7.40 from $11.80 previously

      1/7/22 4:42:16 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Barclays initiated coverage on Tilray with a new price target

      Barclays initiated coverage of Tilray with a rating of Underweight and set a new price target of $10.00

      11/18/21 5:10:04 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray downgraded by Cantor Fitzgerald with a new price target

      Cantor Fitzgerald downgraded Tilray from Overweight to Neutral and set a new price target of $11.80 from $18.00 previously

      11/1/21 7:50:22 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • CIBC reiterated coverage on Tilray with a new price target

      CIBC reiterated coverage of Tilray with a rating of Neutral and set a new price target of $12.00 from $14.00 previously

      10/8/21 7:28:21 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cantor Fitzgerald reiterated coverage on Tilray with a new price target

      Cantor Fitzgerald reiterated coverage of Tilray with a rating of Overweight and set a new price target of $18.00 from $19.00 previously

      9/17/21 4:45:40 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care

    Tilray Brands Inc. Financials

    Live finance-specific insights

    See more
    • Tilray Brands Reports Q3 Fiscal 2025 Financial Results

      Tilray Confirms No Current Impact of Tariffs Generated Net Revenue of $186 Million in the Third Quarter, $193 Million in Constant Currency; Strategic Initiatives and SKU Rationalization Impacted Revenue by $13 Million Tilray Beverage Expands U.S. Distribution of Hemp-Derived THC Drinks Across 10 States, Increases Project 420 Cost Savings Plan to $33 Million Tilray Cannabis Increased Gross Margins by 800 bps, Remains the Leader in Canada by Sales Performance, and Generates Strong Sales Growth in Germany Strengthens Balance Sheet with Convertible Note Reduction of $58 Million and Total Debt Reduction of $71 Million, $248 Million Available in Cash and Marketable Securities NEW Y

      4/8/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands, Inc. to Announce Third Quarter Fiscal 2025 Financial Results on April 8, 2025

      NEW YORK and LEAMINGTON, Ontario, March 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced that the Company will release financial results for its third quarter fiscal 2025 ended February 28, 2025 before financial markets open on April 8, 2025. Live Conference Call and Audio Webcast Tilray will hold a live conference call, which will be webcast, to discuss these results at 8:30 a.m. Eastern Time. The webcast can be accessed in the Investors section of Tilray's website at www.Tilray.com. About Tilray Bran

      3/27/25 4:30:00 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Reports Q2 2025 Financial Results

      Gross Profit Increased by 29% Year-Over-Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments Achieved 9% Year-Over-Year Growth, Generating Record Q2 Net Revenue of $211 Million, 10% in Constant Currency Beverage Revenue Increase by 36%, International Cannabis by 25%, Wellness Segment by 13% Announces Project 420: A $25 Million Synergy Plan for Tilray Beverage Business Tilray Reaffirms Fiscal Year 2025 Guidance Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods co

      1/10/25 7:00:50 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Moves Earnings Date to January 10, 2025, in Observance of the National Day of Mourning

      NEW YORK and LEAMINGTON, Ontario, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will now release its financial results for the second quarter ended November 30, 2024, before the financial market opens on January 10, 2025. The Company originally scheduled the release of its second quarter financial results before market open on January 9, 2025. This change reflects the observance of the National Day of Mourning in honor of former President Jimmy Carter. Live Conference Call and Audio Webcast Tilray will host a live conference call, w

      1/2/25 5:47:32 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands, Inc. to Announce Second Quarter Fiscal Year 2025 Financial Results on January 9, 2025

      NEW YORK and LEAMINGTON, Ontario, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will release its financial results for the second quarter ended November 30, 2024 before the financial market opens on January 9, 2025. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 a.m. Eastern Time. The webcast can be accessed on the Investors section of Tilray's website at www.Tilray.com. About Tilray Brands Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY

      12/19/24 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Reports Q1 2025 Financial Results

      Tilray Achieves 13% Year-Over-Year Growth, Generating Record Q1 Net Revenue of $200 Million Q1 Gross Margin Increases Over 500 Basis Points, Representing 20% Year-Over-Year Growth Tilray Beverages Achieves 132% Net Revenue Growth, Tilray Alternative Beverages Launched in October to Fuel Key U.S. Markets with Hemp-Derived Delta-9 THC Products German Medical Cannabis Flower Revenue Increases by 50% Following Legalization Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, tod

      10/10/24 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2025 Financial Results on October 10, 2024

      NEW YORK and LEAMINGTON, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will release its financial results for the first quarter which ended August 31, 2024 before the financial market opens on October 10, 2024. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 am Eastern Time. The webcast can be accessed on the Investors section of Tilray's website at www.Tilray.com. Investor Q&A Tilray Brands stockholders can submit and upvote question

      9/30/24 3:39:10 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results

      Achieved Net Revenue of $188 Million, ~ 30% Net Revenue Growth Over the Prior Year Quarter Beverage-Alcohol Net Revenue Increases 165% Over the Prior Year Quarter, 5th Largest Craft Beer Brewer in the U.S.1 with 4.5% Craft Beer Market Share Global Cannabis Net Revenue Increases 33% with International Cannabis Growth of 44% Over the Prior Year Quarter, #1 Market Share in Canada and #1 Market Share in Germany U.S. Cannabis Strategy in Place to Strike with Potential Drug Policy Reform Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, April 09, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a

      4/9/24 7:00:00 AM ET
      $BUD
      $TLRY
      Beverages (Production/Distribution)
      Consumer Staples
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Delivers Record Q2 Fiscal 2024 Net Revenue

      Record Q2 Net Revenue of $194 Million, Increases 34% Over the Prior Year Period Global Cannabis Leader with #1 Market Share in Canada and 31% Growth in Canadian Cannabis Net Revenue, Medical Cannabis Leader in Europe with 55% Growth in International Cannabis Net Revenue 5th Largest Craft Beer Brewer in the U.S.1, Positioned to Become Top 12 Beverage-Alcohol Company with 117% Increase in Beverage Alcohol Net Revenue Over the Prior Year Period On Track to Achieve $30-$35 Million in Annual Savings related to Integration of HEXO Acquisition Reiterates Financial Guidance for Fiscal Year 2024 Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Jan. 09, 2024 (

      1/9/24 7:00:00 AM ET
      $BUD
      $TLRY
      Beverages (Production/Distribution)
      Consumer Staples
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Reports Q1 2024 Financial Results

      Record Q1 Net Revenue of $177 Million, Representing 15% Growth Year over Year Increased #1 Cannabis Market Share Position in Canada to 13.4% Grew Canadian Cannabis Revenue by 16.5% and International Cannabis Revenue by 37% With Closing of Acquisition of Eight Craft Beer and Beverage Brands, Creating 5th Largest U.S. Craft Beer Brewer with 5% Market Share in Growing Craft Market Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today reported financial results for

      10/4/23 7:00:00 AM ET
      $BUD
      $TLRY
      Beverages (Production/Distribution)
      Consumer Staples
      Medicinal Chemicals and Botanical Products
      Health Care

    Tilray Brands Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Merton Carl A bought $35,360 worth of shares (26,000 units at $1.36) (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      11/18/24 11:29:05 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Faltischek Denise M bought $20,500 worth of shares (10,000 units at $2.05), increasing direct ownership by 4% to 293,269 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      1/18/24 8:32:10 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Gendel Mitchell bought $14,256 worth of shares (7,200 units at $1.98), increasing direct ownership by 4% to 195,796 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      1/16/24 1:07:47 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Gendel Mitchell bought $10,098 worth of shares (5,400 units at $1.87), increasing direct ownership by 3% to 188,596 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      1/12/24 3:39:01 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Simon Irwin D bought $100,956 worth of shares (53,700 units at $1.88), increasing direct ownership by 3% to 2,033,058 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      1/12/24 3:36:49 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Merton Carl A bought $37,400 worth of shares (20,000 units at $1.87) (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      1/12/24 3:36:08 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care

    Tilray Brands Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Tilray Brands' Stockholders Approve Reverse Stock Split; Company Pauses Implementation as It Evaluates Timing and Stock Price

      NEW YORK and LEAMINGTON, Ontario, June 10, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that the vote for an amendment of the Company's Fifth Amended and Restated Certificate of Incorporation, in order to implement a reverse stock split of the Company's common stock at a ratio ranging from 1-to-10 to 1-to-20 (the "Reverse Stock Split"), passed at the special meeting of stockholders. The Company also announced a pause on the implementation of the newly-authorized reverse stock split while further explo

      6/10/25 4:05:00 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Manitoba Harvest and Whole Foods Market Collaborate to Launch New Protein-Packed, Hemp+ Superfood Smoothie Boosters

      Global Superseed Leader, Manitoba Harvest, Expands their Wellness Lineup with Smoothie Blends for Enhanced Nutrition Plus Energy, Mood and Immune Support NEW YORK and WINNIPEG, Manitoba, June 10, 2025 (GLOBE NEWSWIRE) -- Manitoba Harvest, the global leader in hemp foods and a wellness business by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), has expanded its protein-packed, Hemp+ portfolio to introduce three herbal-infused smoothie boosters: Manitoba Harvest Hemp+ Mood, Manitoba Harvest Hemp+ Energy and Manitoba Harvest Hemp+ Immunity, now exclusively available at select Whole Foods Market stores nationwide. As a global pioneer in protein-packed, seed-based foods, Manitoba Harvest is de

      6/10/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Attention Craft Beer Fans! Tilray Beverages Highlights Boldest Brews For Summer

      ATLANTA, June 05, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, is turning up the heat this summer with a bold lineup of craft beers from its renowned breweries—Atwater Brewery, Blue Point Brewing, Breckenridge Brewery, Montauk Brewing, Shock Top, SweetWater Brewing Co., Terrapin Beer Co., and Widmer Brother's Brewing. These fresh brews are crafted to complement every sun-soaked adventure, from beachside lounging to backyard BBQs. "Summer is the perfect time to embrace crisp, sessionable brews with bright flavors," said Prinz Pinakatt, Chief

      6/5/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SweetWater Brewing and Zoo Atlanta Celebrate 18 Years of Collaboration with a Special Edition Beer

      ATLANTA, May 29, 2025 (GLOBE NEWSWIRE) -- SweetWater Brewing Company ("SweetWater Brewing" or "SweetWater"), the largest craft brewer in the Southeast and a Tilray Brands, Inc. company (NASDAQ:TLRY, TSX:TLRY) is thrilled to extend their partnership with Zoo Atlanta for an 18th year, making it one of the longest running partnerships in the SweetWater's history. Adding a splash of color to summer with its latest limited-edition brew, Pink Flamboyance Lager, marks a true collaboration between the two iconic Atlanta brands. Inspired by the elegance and playful spirit of the flamingoes at Zoo Atlanta, this crisp and refreshing beer blends smooth floral notes with a fresh, lively finish. And yes

      5/29/25 8:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands to Present at TD Cowen's 9th Annual Future of the Consumer Conference

      NEW YORK and LEAMINGTON, Ontario, May 29, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that Irwin D. Simon, Chairman and Chief Executive Officer, and Carl Merton, Chief Financial Officer, will participate in a fireside chat and host one-on-one meetings at the TD Cowen 9th Annual Future of the Consumer Conference on June 3, 2025, in New York, NY. The fireside chat is scheduled for 11:00 a.m. ET and a webcast will be available on Events & Presentations section of Tilray's Investor Relations website. To schedule a one-o

      5/29/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Introducing Y'all's Beer: A True Taste of Texas from Revolver Brewing

      GRANBURY, Texas, May 22, 2025 (GLOBE NEWSWIRE) --  Revolver Brewing, a craft beer pioneer in North Texas and craft beer brand by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), known for crafting bold and uniquely Texan beers, is proud to unveil its latest creation: ‘Y'all's Beer'— a crisp, refreshing lager brewed for good times, great taste, and the kind of camaraderie that brings people together. Y'all's Beer is cold, crisp, and endlessly crushable. It's our tribute to classic American lagers—simple, satisfying, and made for sharing. Crafted with premium ingredients and a modest 4.0% ABV, this easy-drinking lager celebrates the everyday traditions that connect us—whether it's a backyard ha

      5/22/25 8:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Medical Brings Canada's Iconic Cannabis Brand Good Supply to Germany

      NEUMÜNSTER, Germany, May 22, 2025 (GLOBE NEWSWIRE) -- Tilray Medical ("Tilray"), a division of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, is pleased to announce the launch of Good Supply in Germany. Known for its consistent quality and affordability, Good Supply is one of Canada's leading cannabis brands and is recognized as a leading cannabis whole flower with its range of cultivars. The introduction of Good Supply in Germany aims to address the evolving medical cannabis landscape, providing

      5/22/25 7:00:49 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • The $600B Beverage Shift: Why Function Is Outpacing Flavor

      Equity Insider News Commentary Issued on behalf of Safety Shot, Inc. VANCOUVER, B.C., May 20, 2025 /PRNewswire/ -- Equity Insider News Commentary – In the U.S. and abroad, analysts report that consumer interest in "boosted" drinks—those promising anything from gut health to stress relief—is not only rising but redefining how wellness is consumed. RBC's Nik Modi recently told an industry forum that functionality and wellness will dominate beverage growth over the next decade, driven by aging populations and rising demand for convenience. Meanwhile, according to Research and Markets the global market is forecast to swell to nearly $175 billion by 2030, with women and APAC consumers leading the

      5/20/25 7:47:00 AM ET
      $COCO
      $HAIN
      $SHOT
      $TLRY
      Beverages (Production/Distribution)
      Consumer Staples
      Packaged Foods
      Package Goods/Cosmetics
    • Tilray Brands Announces the Launch of XMG Atomic Sours: New THC Beverages and Edibles

      TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, is excited to announce that its wholly-owned subsidiary, High Park Holdings Ltd., is launching XMG Atomic Sours, a new line of cannabis beverages and gummies that redefine the sour experience. XMG Atomic Sours includes two cannabis-infused drinks, Cherry Blasted Lime and Foggy Peaches, and two cannabis-infused gummies, Very Berry Rocket and Cherry Blasted Lime, all crafted to provide consumers with nostalgic sour flavours. XMG Atomic Sours beverages, including Cherry Blast

      5/14/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Shock Top: A Bold Rebrand for a Craft Beer Icon

      PORTLAND, Ore., May 08, 2025 (GLOBE NEWSWIRE) -- Shock Top, a craft beer icon and brand by Tilray Brands, Inc. company (NASDAQ:TLRY, TSX:TLRY), known for its bold flavors and unfiltered wheat ales, today announced a transformative rebrand. With revamped packaging, a new logo, and an expanded, integrated marketing campaign, Shock Top aims to shock a new generation of beer drinkers with a modern look and shocking new seasonal flavors. Building on its legacy of delivering exceptional beers, Shock Top's rebrand introduces a completely new visual identity that enhances its personality and offers a unique experience with every flavor. The new Wedgehead icon is designed as a bolder and more cont

      5/8/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care

    Tilray Brands Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Tilray Brands Inc. (Amendment)

      SC 13G/A - Tilray Brands, Inc. (0001731348) (Subject)

      2/13/23 1:34:44 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G filed by Tilray Brands Inc.

      SC 13G - Tilray Brands, Inc. (0001731348) (Subject)

      2/10/23 4:41:36 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D filed by Tilray Brands Inc.

      SC 13D - Tilray Brands, Inc. (0001731348) (Filed by)

      7/22/22 4:30:22 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D filed by Tilray, Inc.

      SC 13D - Tilray, Inc. (0001731348) (Filed by)

      12/17/21 4:40:18 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed by Tilray, Inc. (Amendment)

      SC 13D/A - Tilray, Inc. (0001731348) (Subject)

      5/25/21 5:03:22 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed

      SC 13D/A - Tilray, Inc. (0001731348) (Subject)

      2/16/21 4:16:09 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed

      SC 13D/A - Tilray, Inc. (0001731348) (Subject)

      2/16/21 4:05:42 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed

      SC 13D/A - Tilray, Inc. (0001731348) (Subject)

      2/16/21 4:02:05 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed

      SC 13G/A - Tilray, Inc. (0001731348) (Subject)

      2/16/21 11:12:08 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed

      SC 13G/A - Tilray, Inc. (0001731348) (Subject)

      2/16/21 10:08:34 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care